サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1253662

医療向け相互運用性ソリューションの世界市場：種類別 (ソフトウェア、サービス)・相互運用性のレベル別・エンドユーザー別・地域別の将来予測 (2027年まで)

Healthcare Interoperability Solutions Market by Type (Software, and Services), Interoperability Level, End User, and Region - Global Forecast to 2027
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 217 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
医療向け相互運用性ソリューションの世界市場：種類別 (ソフトウェア、サービス)・相互運用性のレベル別・エンドユーザー別・地域別の将来予測 (2027年まで)
出版日: 2023年04月03日
発行: MarketsandMarkets
ページ情報: 英文 217 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の医療向け相互運用性ソリューションの市場規模は、2022年の34億米ドルから2027年には62億米ドルに達し、予測期間中に12.9%のCAGRで成長する、と予測されています。

この市場の成長は、効率的で費用対効果の高い医療提供に対する需要の高まり、医療向け相互運用性に対する政府の資金援助、電子カルテ (EHR) の急速な普及によってもたらされます。しかし、標準規格の欠如や老朽化した従来型システムの使用が、予測期間中の市場成長をある程度抑制する要因となっています。

"種類別では、医療情報交換 (HIE) 相互運用性ソリューションが2021年に最も急速に成長した"

種類別に見ると、2021年にはHIE相互運用性ソリューションが最大のシェアを占めています。その要因として、投薬や医療ミスの減少による患者の安全性の向上、不必要な書類作成や処理の排除による効率の向上、より効果的な介護・治療のための臨床意思決定支援ツールの介護者への提供、などが挙げられます。

"相互運用性のレベル別では、基本的な相互運用性が2021年に最大のセグメントとなる"

相互運用性のレベル別に見ると、基本的な相互運用性のセグメントが世界市場で最大のシェアを占めています。その理由として、異種システム間での安全かつ正確なデータ交換の必要性や、費用対効果の高い基本レベルの相互運用性に対する需要の高まりなどが考えられます。

"予測期間中、アジア太平洋が最も高い成長率を達成する"

アジア太平洋は予測期間中に最も高いCAGRで成長すると予測されています。アジア太平洋地域の市場成長は主に、国家的な相互運用性政策を新たに展開し、公的・民間医療機関と既存の政策を練り直すための政府の取り組みの増加、メディカルツーリズムの増加、患者にコスト効率と質の高いケアを提供するための医療機器とHCITソリューションの導入・統合のニーズの高まり、といった要因によってもたらされます。

当レポートでは、世界の医療向け相互運用性ソリューションの市場について分析し、市場の基本構造や最新情勢、主な市場促進・抑制要因、種類別・相互運用性のレベル別・エンドユーザー別・地域別の市場動向の見通し、市場競争の状態、主要企業のプロファイルなどを調査しております。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 価格分析
  • バリューチェーン分析
  • エコシステム分析
  • 技術分析
  • 主な会議とイベント (2023年)
  • 規制分析
  • ポーターのファイブフォース分析
  • 主な利害関係者と購入基準

第6章 医療向け相互運用性ソリューション市場：種類別

  • イントロダクション
  • ソフトウェアソリューション
    • 電子カルテ (EHR) 相互運用性ソリューション
    • ラボシステム相互運用性ソリューション
    • 画像診断システの相互運用性ソリューション
    • 医療情報交換 (HIE) 相互運用性ソリューション
    • 企業用相互運用性ソリューション
    • その他の医療向け相互運用性ソリューション
  • サービス

第7章 医療向け相互運用性ソリューション市場：相互運用性のレベル別

  • イントロダクション
  • 基本的な相互運用性
  • 構造的な相互運用性
  • セマンティックな相互運用性

第8章 医療向け相互運用性ソリューション市場：エンドユーザー別

  • イントロダクション
  • 医療提供者
    • 病院・クリニック
    • 長期介護センター
    • 診断・画像センター
    • その他の医療提供者
  • 支払者
  • 薬局

第9章 医療向け相互運用性ソリューション市場：地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • オランダ
    • 他の欧州諸国
  • アジア太平洋
    • 日本
    • オーストラリア
    • 他のアジア太平洋諸国
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • イントロダクション
  • 医療向け相互運用性ソリューション市場：企業が採用した主な戦略
  • 医療向け相互運用性ソリューション市場：主要企業の市場ランキング
  • 市場シェア分析
  • 主要企業の競合評価クアドラント
  • スタートアップ/中小企業の競合評価クアドラント
  • 競合ベンチマーキング
    • 医療向け相互運用性ソリューション市場：企業の製品フットプリント
    • 医療向け相互運用性ソリューション市場：企業の地域フットプリント
    • 医療向け相互運用性ソリューション市場：企業のフットプリント
  • 競合シナリオ
    • 主な製品/サービスの発売と承認
    • 主な取引

第11章 企業プロファイル

  • 主要企業
    • ORACLE HEALTH
    • EPIC SYSTEMS CORPORATION
    • INFOR, INC.
    • INTERSYSTEMS CORPORATION
    • KONINKLIJKE PHILIPS N.V.
    • VERADIGM LLC
    • COGNIZANT
    • CHANGE HEALTHCARE
    • NEXTGEN HEALTHCARE, INC.
    • MERATIVE
    • MEDICAL INFORMATION TECHNOLOGY, INC.
    • LYNIATE
    • OSP LABS
    • ORION HEALTH GROUP OF COMPANIES
    • ONYX TECHNOLOGY LLC
  • その他の企業
    • VISOLVE
    • JITTERBIT
    • INTERFACEWARE INC.
    • VIRTUSA CORP.
    • CONSENSUS CLOUD SOLUTIONS INC.
    • MPHRX
    • WIPRO
    • EMIDS
    • NALASHAA
    • DEEVITA LLC

第12章 付録

目次
Product Code: HIT 6989

The global healthcare interoperability solutions market is projected to reach USD 6.2 billion by 2027 from USD 3.4 billion in 2022, at a CAGR of 12.9% during the forecast period. Growth in this market is driven by the increased demand for efficient & cost-effective healthcare delivery, government funding for healthcare interoperability, and the rapid adoption of EHR. However, the lack of standards, and the use of outdated legacy systems are some factors restraining the growth of the healthcare interoperability solutions market to a certain extent during the forecast period.

"HIE Interoperability Solutions was the fastest-growing segment in the type of healthcare interoperability solutions market for software solutions in 2021"

HIE Interoperability Solutions accounted for the largest share of healthcare interoperability solutions market for software solutions in 2021. The large share of this segment can be attributed to the associated benefits such as improved patient safety by reducing medication and medical errors, increased efficiency by eliminating unnecessary paperwork and handling, as well as providing caregivers with clinical decision support tools for more effective care and treatment.

"Foundational Interoperability accounted for the largest segment by level of interoperaility in the healthcare interoperability solutions market in 2021"

Based on the level of interoperability, the foundational interoperability segment accounted for the largest share of the global healthcare interoperability solutions market. The large share of the foundational interoperability segment can be attributed to the need for safe and accurate data exchange across disparate systems as well as the growing demand for cost-effective basic-level interoperability.

"APAC to witness the highest growth rate during the forecast period."

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors such as increasing government initiatives to unfold new national interoperability policies and rework existing policies with public and private healthcare organizations, growing medical tourism, and the growing need for the implementation and integration of medical devices and HCIT solutions to provide cost-effective and quality care to patients.

The break-down of primary participants is as mentioned below:

  • By Company Type - Tier 1: 55%, Tier 2: 30%, and Tier 3: 15%
  • By Designation - C-level: 50%, Director-level: 35%, and Others: 15%
  • By Region - North America: 48%, Europe: 32%, Asia Pacific: 15%, and Rest of the World: 5%.

Key players in the Healthcare interoperability solutions Market

The key players operating in the healthcare interoperability solutions market include Oracle Health (US), Epic Systems Corporation (US), Infor, Inc. (US), InterSystems Corporation (US), Koninklijke Philips N.V. (Netherlands), Veradigm LLC (US), Cognizant (US), Change Healthcare (US), NextGen Healthcare, Inc. (US), Merative (US), Medical Information Technology, Inc. (US), Lyniate (US), OSP Labs (US), Orion Health Group of Companies (New Zealand), Onyx Technology LLC (US). Some other players in the market include ViSolve (US), Jitterbit (US), iNTERFACEWARE Inc. (Canada), Virtusa Corp. (US), Consensus Cloud Solutions Inc. (US), MphRx (US), Wipro (India), eMids (US), Nalashaa (US), Deevita LLC (US).

Research Coverage:

The report analyzes the healthcare interoperability solutions market and aims at estimating the market size and future growth potential of various market segments, based on type, level of interoperability, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

  • Analysis of key drivers (increasing demand for efficient and cost-effective healthcare delivery, government initiatives and regulations to enhance patient care and safety, emergence of new medical technologies, growing adoption of electronic health records), restraints (lack of accurate interoperability solutions across healthcare supply chain, lack of standards and protocols in IT businesses, use of outdated legacy systems in hospitals and clinic chains), opportunities (growing markets for healthcare interoperability solutions in developing countries, advancements in software technology for real-time data exchange),and challenges (increasing complexity due to lack of consistent data, shortage of skilled healthcare IT professionals, patient data security and privacy concerns in healthcare industry)influencing the growth of the healthcare interoperability solutions market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare interoperability solutions market.
  • Market Development: Comprehensive information on the lucrative emerging markets, type, level of interoperability, end user, and region.
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the healthcare interoperability solutions market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the healthcare interoperability solutions market like Oracle Health (US), Epic Systems Corporation (US), Infor, Inc. (US), InterSystems Corporation (US), Koninklijke Philips N.V. (Netherlands).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION
    • 1.2.3 YEARS CONSIDERED
  • 1.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Insights from primary experts
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 5 CAGR PROJECTIONS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • 2.2.1 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET RANKING ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
  • 2.8 IMPACT OF ECONOMIC RECESSION ON HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • 2.8.1 IMPACT OF RUSSIA-UKRAINE WAR
    • 2.8.2 IMPACT OF INFLATION

3 EXECUTIVE SUMMARY

    • FIGURE 7 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 9 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2022 VS. 2027 (USD MILLION)
    • FIGURE 10 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 11 GEOGRAPHICAL SNAPSHOT OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET

4 PREMIUM INSIGHTS

  • 4.1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW
    • FIGURE 12 GOVERNMENT INITIATIVES FOR ENHANCED PATIENT CARE AND SAFETY TO DRIVE MARKET
  • 4.2 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE AND COUNTRY (2021)
    • FIGURE 13 SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET IN 2021
  • 4.3 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
    • FIGURE 14 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • 4.4 REGIONAL MIX: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET (2022-2027)
    • FIGURE 15 NORTH AMERICA TO DOMINATE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET DURING FORECAST PERIOD
  • 4.5 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS, 2022 VS. 2027
    • FIGURE 16 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 17 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for efficient and cost-effective healthcare delivery
      • 5.2.1.2 Government initiatives and regulations to enhance patient care and safety
      • 5.2.1.3 Emergence of new medical technologies
      • 5.2.1.4 Growing adoption of electronic health records
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Lack of accurate interoperability solutions across healthcare supply chain
      • 5.2.2.2 Lack of standards and protocols in IT businesses
      • 5.2.2.3 Use of outdated legacy systems in hospitals and clinic chains
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing markets for healthcare interoperability solutions in developing countries
      • 5.2.3.2 Advancements in software technology for real-time data exchange
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Increasing complexity due to lack of consistent data
      • 5.2.4.2 Shortage of skilled healthcare IT professionals
      • 5.2.4.3 Patient data security and privacy concerns in healthcare industry
  • 5.3 PRICING ANALYSIS
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 18 VALUE CHAIN ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
  • 5.5 ECOSYSTEM ANALYSIS
    • FIGURE 19 ECOSYSTEM ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
  • 5.6 TECHNOLOGY ANALYSIS
    • 5.6.1 APPLICATION PROGRAMMING INTERFACES
    • 5.6.2 CLOUD-BASED SOLUTIONS
    • 5.6.3 BLOCKCHAIN TECHNOLOGY
    • 5.6.4 FAST HEALTHCARE INTEROPERABILITY RESOURCES
    • 5.6.5 ARTIFICIAL INTELLIGENCE
    • 5.6.6 MACHINE LEARNING
  • 5.7 KEY CONFERENCES AND EVENTS IN 2023
    • TABLE 2 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
  • 5.8 REGULATORY ANALYSIS
    • 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.8.2 LAWS, REGULATIONS, AND STANDARDS
    • TABLE 7 KEY REGULATIONS AND STANDARDS GOVERNING HEALTHCARE INTEROPERABILITY TECHNOLOGIES GLOBALLY
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 20 PORTER'S FIVE FORCES ANALYSIS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • TABLE 8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
    • TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS (%)
    • 5.10.2 BUYING CRITERIA
    • FIGURE 22 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
    • TABLE 10 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS

6 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 11 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 6.2 SOFTWARE SOLUTIONS
    • TABLE 12 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 13 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.1 EHR INTEROPERABILITY SOLUTIONS
      • 6.2.1.1 Large installation base of EHR systems to ensure single and continuous readable documents for physicians
    • TABLE 14 EHR INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
    • TABLE 15 EHR INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.2 LAB SYSTEM INTEROPERABILITY SOLUTIONS
      • 6.2.2.1 Increasing cost of operations and decreasing reimbursements for laboratory services to boost market
    • TABLE 16 LAB SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
    • TABLE 17 LAB SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.3 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS
      • 6.2.3.1 Rising need for data interoperability and increasing usage of smart devices to drive market
    • TABLE 18 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
    • TABLE 19 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.4 HIE INTEROPERABILITY SOLUTIONS
      • 6.2.4.1 Large investments by federal governments to propel market
    • TABLE 20 HIE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
    • TABLE 21 HIE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.5 ENTERPRISE INTEROPERABILITY SOLUTIONS
      • 6.2.5.1 Advancing software technology and rising demand for expanded care delivery to augment market
    • TABLE 22 ENTERPRISE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
    • TABLE 23 ENTERPRISE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.6 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS
    • TABLE 24 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
    • TABLE 25 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.3 SERVICES
    • 6.3.1 INCREASING ADOPTION OF HEALTHCARE IT INTEGRATION SERVICES BY PROVIDERS TO AUGMENT MARKET
    • TABLE 26 SERVICES OFFERED BY KEY PLAYERS
    • TABLE 27 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2020-2027 (USD MILLION)

7 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL

  • 7.1 INTRODUCTION
    • TABLE 28 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
  • 7.2 FOUNDATIONAL INTEROPERABILITY
    • 7.2.1 NEED FOR SAFE AND ACCURATE DATA EXCHANGE ACROSS DISPARATE SYSTEMS TO FUEL MARKET
    • TABLE 29 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR FOUNDATIONAL INTEROPERABILITY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.3 STRUCTURAL INTEROPERABILITY
    • 7.3.1 STRUCTURAL INTEROPERABILITY TO ENSURE INTERPRETATION OF DATA EXCHANGE BETWEEN SYSTEMS AT DATA FIELD LEVEL
    • TABLE 30 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR STRUCTURAL INTEROPERABILITY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.4 SEMANTIC INTEROPERABILITY
    • 7.4.1 SEMANTIC INTEROPERABILITY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
    • TABLE 31 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SEMANTIC INTEROPERABILITY, BY COUNTRY, 2020-2027 (USD MILLION)

8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 32 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 8.2 HEALTHCARE PROVIDERS
    • TABLE 33 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 34 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.2.1 HOSPITALS & CLINICS
      • 8.2.1.1 Increasing patient volume and rising need to reduce errors in data management to augment market
    • TABLE 35 HOSPITALS & CLINICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.2.2 LONG-TERM CARE CENTERS
      • 8.2.2.1 Increasing number of care centers and need to maintain compliance with medical reforms to propel market
    • TABLE 36 LONG-TERM CARE CENTERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.2.3 DIAGNOSTIC & IMAGING CENTERS
      • 8.2.3.1 Increasing volume of clinical data and need to streamline imaging workflows to drive market
    • TABLE 37 DIAGNOSTIC & IMAGING CENTERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.2.4 OTHER HEALTHCARE PROVIDERS
    • TABLE 38 OTHER HEALTHCARE PROVIDERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.3 HEALTHCARE PAYERS
    • 8.3.1 ADOPTION OF HEALTHCARE INTEROPERABILITY BY PAYERS TO DECREASE HOSPITAL STAYS AND REPEAT TESTS
    • TABLE 39 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.4 PHARMACIES
    • 8.4.1 PHARMACIES TO USE HEALTHCARE INFORMATION EXCHANGE SOLUTIONS FOR INDIVIDUALIZED PATIENT CARE AND SUPPORT
    • TABLE 40 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR PHARMACIES, BY COUNTRY, 2020-2027 (USD MILLION)

9 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 41 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 23 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT
    • TABLE 42 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 43 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 44 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 45 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 46 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 47 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 Growing need to curtail healthcare costs to drive market
    • TABLE 48 US: KEY MACROINDICATORS
    • TABLE 49 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 50 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 51 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 52 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 53 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Increasing healthcare digitization to support market
    • TABLE 54 CANADA: KEY MACROINDICATORS
    • TABLE 55 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 56 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 57 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 58 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 59 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 60 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 61 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 62 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 63 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 64 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 65 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Modernized healthcare system and increased healthcare expenditure to augment market
    • TABLE 66 GERMANY: KEY MACROINDICATORS
    • TABLE 67 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 68 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 69 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 70 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 71 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Government initiatives and NHS programs to drive demand
    • TABLE 72 UK: KEY MACROINDICATORS
    • TABLE 73 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 74 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 75 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 76 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 77 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Government measures to curtail healthcare expenditures to fuel market
    • TABLE 78 FRANCE: KEY MACROINDICATORS
    • TABLE 79 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 80 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 81 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 82 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 83 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Increasing government initiatives in HCIT technology implementation to aid market
    • TABLE 84 ITALY: KEY MACROINDICATORS
    • TABLE 85 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 86 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 87 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 88 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 89 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.5 NETHERLANDS
      • 9.3.5.1 Robust healthcare infrastructure and eHealth initiatives to propel market
    • TABLE 90 NETHERLANDS: KEY MACROINDICATORS
    • TABLE 91 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 92 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 93 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 94 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 95 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 96 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 97 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 98 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 99 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 100 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 24 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT
    • TABLE 101 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 102 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 103 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 104 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 105 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 106 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.4.1 JAPAN
      • 9.4.1.1 Japan to be largest healthcare interoperability market in Asia Pacific during forecast period
    • TABLE 107 JAPAN: KEY MACROINDICATORS
    • TABLE 108 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 109 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 110 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 111 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 112 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.4.2 AUSTRALIA
      • 9.4.2.1 Increasing government initiatives for better clinical communication to drive market
    • TABLE 113 AUSTRALIA: KEY MACROINDICATORS
    • TABLE 114 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 115 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 116 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 117 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 118 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 9.4.3 REST OF ASIA PACIFIC
    • TABLE 119 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 120 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 121 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 122 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 123 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 IMPLEMENTATION OF FAVORABLE GOVERNMENT INITIATIVES TO DRIVE MARKET
    • TABLE 124 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 125 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 126 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 127 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 128 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 INCREASED ESTABLISHMENT OF NEW HOSPITALS TO DRIVE MARKET
    • TABLE 129 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 130 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 131 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 132 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 133 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY STRATEGIES ADOPTED BY PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • TABLE 134 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: KEY DEVELOPMENTS (JANUARY 2019-MARCH 2023)
  • 10.3 MARKET RANKING OF KEY PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • FIGURE 25 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: MARKET RANKING OF KEY PLAYERS (2022)
  • 10.4 MARKET SHARE ANALYSIS
    • 10.4.1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • TABLE 135 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2021
  • 10.5 COMPETITIVE EVALUATION QUADRANT FOR KEY PLAYERS
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • FIGURE 26 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING (2022)
  • 10.6 COMPETITIVE EVALUATION QUADRANT FOR START-UPS/SMES
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 DYNAMIC COMPANIES
    • 10.6.3 STARTING BLOCKS
    • 10.6.4 RESPONSIVE COMPANIES
    • FIGURE 27 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2022)
  • 10.7 COMPETITIVE BENCHMARKING
    • 10.7.1 PRODUCT FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • TABLE 136 COMPANY PRODUCT FOOTPRINT
    • 10.7.2 REGIONAL FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • TABLE 137 COMPANY REGION FOOTPRINT
    • 10.7.3 FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET
    • TABLE 138 COMPANY FOOTPRINT
  • 10.8 COMPETITIVE SCENARIO
    • 10.8.1 KEY PRODUCT/SERVICE LAUNCHES AND APPROVALS
    • TABLE 139 KEY PRODUCT/SERVICE LAUNCHES AND APPROVALS, 2019-2022
    • 10.8.2 KEY DEALS
    • TABLE 140 KEY DEALS, 2019-2022

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS

(Business Overview, Products/Services/Solutions offered, Recent Developments, and MnM View)*

    • 11.1.1 ORACLE HEALTH
    • TABLE 141 ORACLE HEALTH: COMPANY OVERVIEW
    • FIGURE 28 ORACLE HEALTH: COMPANY SNAPSHOT (2021)
    • 11.1.2 EPIC SYSTEMS CORPORATION
    • TABLE 142 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
    • 11.1.3 INFOR, INC.
    • TABLE 143 INFOR, INC.: COMPANY OVERVIEW
    • FIGURE 29 INFOR, INC.: COMPANY SNAPSHOT (2019)
    • 11.1.4 INTERSYSTEMS CORPORATION
    • TABLE 144 INTERSYSTEMS CORPORATION: COMPANY OVERVIEW
    • 11.1.5 KONINKLIJKE PHILIPS N.V.
    • TABLE 145 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
    • FIGURE 30 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021)
    • 11.1.6 VERADIGM LLC
    • TABLE 146 VERADIGM LLC: COMPANY OVERVIEW
    • FIGURE 31 VERADIGM LLC: COMPANY SNAPSHOT (2021)
    • 11.1.7 COGNIZANT
    • TABLE 147 COGNIZANT: COMPANY OVERVIEW
    • FIGURE 32 COGNIZANT: COMPANY SNAPSHOT (2021)
    • 11.1.8 CHANGE HEALTHCARE
    • TABLE 148 CHANGE HEALTHCARE: COMPANY OVERVIEW
    • FIGURE 33 CHANGE HEALTHCARE: COMPANY SNAPSHOT (2021)
    • 11.1.9 NEXTGEN HEALTHCARE, INC.
    • TABLE 149 NEXTGEN HEALTHCARE, INC.: COMPANY OVERVIEW
    • FIGURE 34 NEXTGEN HEALTHCARE, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.10 MERATIVE
    • TABLE 150 MERATIVE: COMPANY OVERVIEW
    • 11.1.11 MEDICAL INFORMATION TECHNOLOGY, INC.
    • TABLE 151 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY OVERVIEW
    • FIGURE 35 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY SNAPSHOT (2019)
    • 11.1.12 LYNIATE
    • TABLE 152 LYNIATE: COMPANY OVERVIEW
    • 11.1.13 OSP LABS
    • TABLE 153 OSP LABS: COMPANY OVERVIEW
    • 11.1.14 ORION HEALTH GROUP OF COMPANIES
    • TABLE 154 ORION HEALTH GROUP OF COMPANIES: COMPANY OVERVIEW
    • FIGURE 36 ORION HEALTH GROUP OF COMPANIES: COMPANY SNAPSHOT (2021)
    • 11.1.15 ONYX TECHNOLOGY LLC
    • TABLE 155 ONYX TECHNOLOGY LLC: COMPANY OVERVIEW
  • 11.2 OTHER PLAYERS
    • 11.2.1 VISOLVE
    • TABLE 156 VISOLVE: COMPANY OVERVIEW
    • 11.2.2 JITTERBIT
    • TABLE 157 JITTERBIT: COMPANY OVERVIEW
    • 11.2.3 INTERFACEWARE INC.
    • TABLE 158 INTERFACEWARE INC.: COMPANY OVERVIEW
    • 11.2.4 VIRTUSA CORP.
    • TABLE 159 VIRTUSA CORP.: COMPANY OVERVIEW
    • FIGURE 37 VIRTUSA CORP.: COMPANY SNAPSHOT (2020)
    • 11.2.5 CONSENSUS CLOUD SOLUTIONS INC.
    • TABLE 160 CONSENSUS CLOUD SOLUTIONS INC.: COMPANY OVERVIEW
    • 11.2.6 MPHRX
    • 11.2.7 WIPRO
    • 11.2.8 EMIDS
    • 11.2.9 NALASHAA
    • 11.2.10 DEEVITA LLC
  • Business Overview, Products/Services/Solutions offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS